Vol. 8 (02) pp. 607-609 DOI: 10.21474/IJAR01/10492

RADIOTHERAPY FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

and
  • Mohammed VI University of Health Sciences (UM6SS). Casablanca, Morocco, Department of Medical Hematology, International University Hospital Sheikh Khalifa.
  • Mohammed VI University of Health Sciences (UM6SS). Casablanca, Morocco, Department of Radiotherapy, International University Hospital Sheikh Khalifa.
14 Downloads 60 Views
Crossref

Download Full Paper (PDF)

Article Analytics

References

  1. Patrick Y. Wen. Point/Counterpoint: Is there a role for radiotherapy in the treatment of primary CNS lymphoma?. Neuro-Oncology 16(8), 1032, 2014 doi:10.1093/neuonc/nou135
  2. Tommy Sheu MD , Sarah A. Milgrom MD , Therese Y. Andraos MD and al.Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy. Advances in Radiation Oncology (2018) 3, 639-646
  3. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin?s lymphoma of the brain: can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9?17.
  4. Korfel A, Thiel E, Martus P,et al. Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology. 2015;84:1242.
  5. Herrlinger U, Schafer N, Fimmers R, et al.Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. J Cancer Res Clin Oncol DOI: 10.1007/s00432?017?2423?5.
  6. Herrlinger U, Schafer N, Fimmers R, et al.Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial. J Cancer Res Clin Oncol DOI: 10.1007/s00432?017?2423?5.
  7. Morris PG, Correa DD, Yahalom J, Raizer JJ, Schiff D, Grant B, Grimm S, Lai RK, Reiner AS, Panageas K, Karimi S, Curry R, Shah G, et al. Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome. J Clin Oncol. 2013; 31:3971?3979.
  8. Jun Su Park, Do Hoon Lim,Yong Chan Ahn and al . Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy .Japanese Journal of Clinical Oncology, 2017, 47(11) 995?1001
  9. ]Berry MP, Simpson WJ. Radiation therapy in the management of primary malignant lymphoma of the brain. Int J Radiat Oncol Biol Phys 1981;7: 55?9.

How to Cite This Article

N. Bouanani and F. Kouhen (2020); RADIOTHERAPY FOR PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA, Int. J. of Adv. Res., 8 (02), 607-609, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/10492

Corresponding Author

F.Kouhen
Mohammed VI University of Health Sciences (UM6SS)
Creative Commons Attribution 4.0 This work is licensed under a Creative Commons Attribution 4.0 International License.